Clinical Trial

SHR-1811 Combined With Carboplatin in the Treatment of Advanced Breast Cancer With HER2 Expression

Name: SHR-1811 Combined With Carboplatin in the Treatment of Advanced Breast Cancer With HER2 Expression — clinical trial record (NCT07047443)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To find the optimal dose of carboplatin combined with SHR-A1811 in her2-expressed metastatic breast cancer

Trial Details

NCT Number	NCT07047443
Lead Sponsor	Anhui Provincial Cancer Hospital
Conditions	Breast Cancer
Enrollment	18 participants
Start Date	2025-08-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-07-02